YouDiagnose is Drug Discovery in United Kingdom that focus on developer business. Founded in 2020. They cover business area such as developer, cancer diagnosis system, cancer care, predictive diagnosis, risk assessment, triage, management, care pathway, its AI-enable, datum-drive, multi-disciplinary, personalized, evidence-base approach, making, patient, doctor, caretaker, quality, life and cancer survival.
2020
( 4 years old in 2024 )
Developer
-
27 Old Gloucester Street
London WC1N 3AX
England, United Kingdom
Private
developercancer diagnosis systemcancer carepredictive diagnosisrisk assessmenttriagemanagementcare pathwayits AI-enable, datum-drive, multi-disciplinary, personalized, evidence-base approachmakingpatientdoctorcaretakerqualitylife and cancer survival
* We use standard office opening hours in near YouDiagnose's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
YouDiagnose is Drug Discovery business from United Kingdom that founded in 2020 (4 years old in 2024), YouDiagnose business is focusing on Developer.
YouDiagnose headquarter office and corporate office address is located in 27 Old Gloucester Street London WC1N 3AX England, United Kingdom.
YouDiagnose was founded in United Kingdom.
In 2024, YouDiagnose is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with YouDiagnose, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
